| Title |
Elimination of high-risk human papillomavirus type HPV16 infection by ‘Praneem’ polyherbal tablet in women with early cervical intraepithelial lesions
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, June 2009
|
| DOI | 10.1007/s00432-009-0617-1 |
| Pubmed ID | |
| Authors |
Shirish Shukla, Alok C. Bharti, Showket Hussain, Sutapa Mahata, Suresh Hedau, Uma Kailash, Veena Kashyap, Suresh Bhambhani, Meera Roy, Swaraj Batra, G. P. Talwar, Bhudev C. Das |
| Abstract |
'Praneem', a polyherbal formulation developed by us, has successfully completed Phase II efficacy study for treatment of abnormal vaginal discharge due to reproductive tract infections that act as co-factors for HPV persistence. In the present study we evaluated potential anti-HPV activity of Praneem in women infected with high risk HPV type 16. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| United States | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 61 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 20% |
| Student > Ph. D. Student | 11 | 17% |
| Researcher | 10 | 16% |
| Student > Postgraduate | 6 | 9% |
| Other | 6 | 9% |
| Other | 10 | 16% |
| Unknown | 8 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 31% |
| Social Sciences | 8 | 13% |
| Biochemistry, Genetics and Molecular Biology | 7 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
| Agricultural and Biological Sciences | 5 | 8% |
| Other | 7 | 11% |
| Unknown | 12 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2016.
All research outputs
#14,065,859
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#1,277
of 2,632 outputs
Outputs of similar age
#95,156
of 115,064 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#6
of 6 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,064 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.